Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$3.52 - $9.59 $375,848 - $1.02 Million
106,775 Added 76.03%
247,209 $927,000
Q4 2023

Feb 14, 2024

BUY
$5.97 - $10.36 $462,686 - $802,920
77,502 Added 123.15%
140,434 $1.38 Million
Q3 2023

Nov 14, 2023

BUY
$8.23 - $13.93 $517,930 - $876,642
62,932 New
62,932 $525,000
Q1 2023

May 15, 2023

SELL
$7.94 - $12.02 $37,667 - $57,022
-4,744 Reduced 18.61%
20,751 $240,000
Q4 2022

Feb 14, 2023

SELL
$5.67 - $11.2 $724,881 - $1.43 Million
-127,845 Reduced 83.37%
25,495 $208,000
Q3 2022

Nov 14, 2022

SELL
$3.93 - $8.57 $2.49 Million - $5.43 Million
-633,030 Reduced 80.5%
153,340 $890,000
Q2 2022

Aug 15, 2022

BUY
$4.02 - $10.43 $658,781 - $1.71 Million
163,876 Added 26.33%
786,370 $3.48 Million
Q1 2022

May 16, 2022

BUY
$8.43 - $20.9 $4.87 Million - $12.1 Million
577,366 Added 1279.4%
622,494 $5.67 Million
Q4 2021

Feb 14, 2022

BUY
$19.26 - $30.08 $869,165 - $1.36 Million
45,128 New
45,128 $923,000
Q1 2021

May 17, 2021

SELL
$26.38 - $51.15 $1.51 Million - $2.93 Million
-57,266 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$10.5 - $28.5 $590,782 - $1.6 Million
56,265 Added 5620.88%
57,266 $1.49 Million
Q3 2020

Nov 16, 2020

SELL
$3.61 - $9.87 $100,700 - $275,323
-27,895 Reduced 96.54%
1,001 $10,000
Q2 2020

Aug 14, 2020

BUY
$2.65 - $4.03 $76,574 - $116,450
28,896 New
28,896 $100,000
Q3 2019

Nov 14, 2019

SELL
$4.99 - $6.16 $22,954 - $28,336
-4,600 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$5.92 - $7.41 $27,232 - $34,086
4,600 New
4,600 $28,000
Q4 2018

Feb 14, 2019

SELL
$3.99 - $7.82 $37,541 - $73,578
-9,409 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$3.52 - $5.55 $33,119 - $52,219
9,409 New
9,409 $51,000
Q4 2017

Feb 14, 2018

SELL
$2.59 - $5.44 $27,132 - $56,989
-10,476 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$3.2 - $5.57 $33,523 - $58,351
10,476
10,476 $55,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.